chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nope got sick as hell on the last one; Initial information received on 17-Feb-2022 regarding an unsolicited valid Social Media non-serious case on page received from a consumer.  This case involves a adult patient of unknown demographics who reported nope got sick as hell on the last one while receiving Influenza Vaccine.  The patient's has no past medical history,concomitant disease or risk factor.   There were no lab data/results available.  On an unknown date, the patient received a  dose of suspect Influenza Vaccine produced by unknown manufacturer (form, strength, route, administration site, batch number not reported) for immunization. Information on Batch number was requested.  On an unknown date the patient reported nope got sick as hell on the last one (illness) (unknown latency) following the administration of Influenza Vaccine.  Action taken was not applicable   Corrective treatment was not reported   Outcome was Unknown
Booster; Tested positive for Covid; Tested positive for Covid; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A 63 year-old male patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMMUNISATION (medically significant), outcome "unknown", described as "Booster"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2021, outcome "unknown" and all described as "Tested positive for Covid". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (2021) tested positive for covid. Clinical course: Patient had his booster dose, he had the 3 series of Pfizer BioNTech Covid 19 vaccine. He had a cold right now that started with a runny nose and sore throat and he got a quick test and he tested positive for Covid. The patient wanted to know if there was anything else he could take for the Omicron variant. The lot number for bnt162b2 was not provided and will be requested during follow up.
Cellultis left upper outer arm, starting at site where PPSV23 given on 2/3/15. Cellulitis migrated down arm and on 2/9/16 only had a ring of slight redness and swelling on left forearm about 2 inches above wrist.
Symptoms began day after vaccines.  Started with vomitting, then non stop crying, and fever of 103.  Did not sleep and even with Infant Tylenol fever would come back in an hour.  Glassy eyes stare, lost interest to play, stopped smiling.  Hands turned blue in color.  Crying and fever lasted for 3 days.  Blue hands lasted for 2 days.
Patient hospitalized for 8 hours.  Patient is a 25yo female who presented at 34w0d with fever, tachycardia, and malaise. Given her symptoms a sepsis workup was completed and was given IV fluid resuscitation and oral tylenol. She was found to be positive for Covid 19. After her fluid resuscitation she felt much better. Her vital signs normalized with a heart rate of 88. The fetal heart rate on arrival was tachycardic in the 170's - this also resolved with fluid resuscitation to a baseline of 145-150, moderate variability, with +accels, no decels. She had a normal WBC count and her CBC and CMP were normal. She did report lower pelvic pain and urinary frequency, although denies dysuria or hematuria. A urinalysis was suspicious for a UTI so she was treated with 3gm fosfomycin. As she did not meet inpatient hospitalization criteria the monoclonal antibody team was consulted and she elected to receive the infusion. This was given while she was in triage. The patient was advised to return to the hospital with any alarming signs/sxs including severe chest pain, shortness of breath, severe abdominal pain or decreased fetal movement. We discussed quarantining due to Covid and will plan to reschedule her next prenatal visit. She was also taught to administer lovenox and was given her first dose of 40mg SQ. A rx was sent for 40mg BID for 10 days for DVT prophylaxis. She felt comfortable with the plan for discharge and had no further questions.
sore arm from the elbow to the shoulder (almost going up to the neck); injection site was itchy; injection site was red; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm from the elbow to the shoulder (almost going up to the neck)), VACCINATION SITE PRURITUS (injection site was itchy) and VACCINATION SITE ERYTHEMA (injection site was red) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm from the elbow to the shoulder (almost going up to the neck)), VACCINATION SITE PRURITUS (injection site was itchy) and VACCINATION SITE ERYTHEMA (injection site was red). At the time of the report, PAIN IN EXTREMITY (sore arm from the elbow to the shoulder (almost going up to the neck)), VACCINATION SITE PRURITUS (injection site was itchy) and VACCINATION SITE ERYTHEMA (injection site was red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported No treatment medication was reported   This case was linked to MOD-2021-031699, MOD-2021-099111, MOD-2021-099111 (Patient Link).
Our facility only has the capability to store COVID19 vaccines in the refrigerator. Patient was given a vaccine that was outside of the 10 week expiration window. The 10 week expiration date was 6/10/22, patient recieved the vaccine on 6/14/22. Patient has not reported any adverse events or symptoms to our facility after recieving the vaccine.
no adverse event; an expired dose of MMR was administered to a patient; This spontaneous report was received from a medical assistant referring to a patient of unknown age.  No information was provided regarding the patient's medical history, concurrent conditions, past drug history or concomitant medications.    On 05-MAY-2021 the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) lot # S013536, 0.5 milliliter for prophylaxis (route and site of administration were not reported) which had expired on 02-MAY-2021.    There was no adverse effect reported. No product quality complaint was involved.
Pt recv vax on 1/30/98; on 2/5/98 pt exp illness w/ cough, decreased appetite, diarrhea & rash; pt cried, fell forward & stopped breathing w/ purple color & eyes rolled back; quiet & pale x 30 min; tx=puffs of air
Inside of mouth felt like sore when have bit/chewed on inner jaws, cheeks red and flushed, H/A, unable to sleep started approximately 11pm. Took BENADRYL x 2 and s/s resolved without cheeks still a little red. No MD eval. Cannot r/t any other thing that came in contact with on 5/7.
Red, swollen, warm to touch at injection site. Per md's instruction pt is going to use ice and Benadryl.
Initial report was received from a consumer on 24 September 2011, who is also the patient. An adult female patient (who was 49 years of age at the time of the report) had received an injection of INFLUENZA VACCINE (manufacturer, lot number, route, site and date of administration unknown) in the late 1980's as an adult. Approximately 15 minutes post vaccination, the patient passed out while still at the doctor's office. The event lasted a few seconds. She was administered what she thought was BENADRYL, felt fine, recovered and then left the office for home. Two days later, she developed a mild rash which lasted two days, and then rash recovered. Allergy testing performed at a later point in time (dates unknown), revealed multiple allergies; including tree nuts, egg yolks, mold and ragweed. The patient stated that her doctor probably reported these events when they occurred and she had no additional information to provide. Documents held by sender: None.
sickness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "sickness". Additional information: Patient experienced sickness symptoms and she is asking if she can still get the second dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Arm very sore , chills , body aches , tired , lasted for about 26 hours
Patient is beyond 35 days for 2nd dose and has not yet received it; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient is beyond 35 days for 2nd dose and has not yet received it) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jul-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient is beyond 35 days for 2nd dose and has not yet received it). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient is beyond 35 days for 2nd dose and has not yet received it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Approximately 45 minutes after the injection, patient's  tongue  felt rough and textured.  Upon viewing, her tongue was red with tiny bumps on the front half.  An hour after that, her saliva felt thick with mucous and her tongue was red and mottled. 4 hours after the injection the red color dissipated, but the tiny bumps remained.  The next morning. her tongue was back to normal.
Pt recvd MMR vax 8APR91 & delivered @ term 25JAN92 female w/small eyes & lt congenital catarract;
Information has been received from a physician concerning a patient who on an unspecified date was vaccinated with the first dose of varicella virus vaccine live. Subsequently, the patient did not trigger an immune response. The patient's titer was "zero". The patient sought unspecified medical attention. Additional information has been requested.
Acute hypoxemic respiratory failure due to COVID-19; Hyponatremia; Pneumonia due to COVID-19 virus
Patient reports a red swollen area (approximately 3 in diameter) around injection site that appeared the morning after the injection.
I felt extremely tired and wiped out for 2 days, wouldn't have been able to work. Experienced hypothermia and a splitting headache. Thankfully it all went away on the morning of the 21st. The reason I am reporting this is because the app misses the days and hours directly after vaccination in their data collection that is reflecting this time frame. So their data is " garbage in - Garbage out".
Received injection on 10/01/2009. Immunization report of pain in upper arm. Next day inner  aspect of arm erythematous, warm and swollen, painful. Has slowly resolved.
Raised and pink rash at injection site, itchy and sore.  Eased with ice and/or steroid cream.
I noticed with my first shot the tip of my right hand pointer finger  was numb for a couple of days then it went away. Second shot three weeks later my right foot the top tight above the toes to my ankle was numb and I felt like I had hit a funny bone on my right ankle. It feels better there already but still numb above my toes.
Headache; Fatigue; Muscle weakness; Exercise intolerance; Photosensitivity; reporter confirmed it was more than 6 months before they received the second dose; Fever; This case was reported by a consumer via call center representative and described the occurrence of fever in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pyrexia (1st dose received on an unknown date, refer case US2021AMR260605).   On 14th December 2021, the patient received the 2nd dose of Shingrix. On 14th December 2021, immediately after receiving Shingrix, the patient experienced fever, headache, fatigue, muscle weakness, exercise tolerance decreased, photosensitivity and drug dose administration interval too long. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the fever was recovered/resolved and the outcome of the headache, fatigue, muscle weakness, exercise tolerance decreased and photosensitivity were not recovered/not resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the fever, headache, fatigue, muscle weakness, exercise tolerance decreased and photosensitivity to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient. The reporter reported immediately experiencing fever, headache, fatigue, muscle weakness, exercise intolerance and photosensitivity. The reporter confirmed it was more than 6 months before they received the second dose, which led to lengthening of vaccination schedule. The fever resolved after approximately 24 hours. The reporter reported all other symptoms were ongoing.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR260605:1st dose case
got my flu shot and im sick is a dog; Initial information received on 19-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer.  This case involves an unknown age and unknown gender patient who experienced "got his/ her flu shot and got sick is a dog" while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number, Expiry date :not reported) via unknown route in unknown administration site (form, strength, dose, frequency: unknown) for flu prophylaxis. information regarding batch number has been requested.  On an unknown date the patient developed a non-serious event "got his/her flu shot and got sick is a dog" (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken with INFLUENZA VACCINE was not applicable.  At time of reporting, the outcome was Unknown for the event.
12/14/2005 2am pt woke up with leg cramp on right thigh, got up to walk and shake leg. While up pt decided to use rest room finished using toilet, next thing she remembers woke up on bathroom floor. Don't know how long passed out or what happened. Sat up felt nausea threw up a little, felt hot and sweaty crawled back next to bed and laid on floor, then husband woke up, pt felt very dizzy and did not want husband to pick her up and place in bed. Felt chills laid there did not sleep. Finally got into bed at 6 pm. Laid in bed x few hours, tried drinking water, room felt like it was spinning, even with eyes closed. Did not seek med attention.
Information has been received from a nurse practitioner and certified medical assistant concerning a  13 year old female who on 24-OCT-2006 was vaccinated intramuscularly into the left deltoid with a first 0.5 mL dose of Gardasil (yeast) (lot# 653937/0637F). There was no concomitant medication. She was administered a second 0.5 ml dose of Gardasil (yeast), intramuscularly (Lot # 653735/0688F) into the right detoid on 26-DEC-2006. There was no illness at the time of vaccination.  It was reported that the patient, who has had her regular menses since the age of 10, had not had her regular menses in November 2006 or December 2006. The medical assistant further reported that the patient's menses stopped in October 2006 after the first dose and she had no menses in November or December 2009. she started her meneses in January 2007 and in Febraury 2007, saw a physician for tests (unspecified). All was reported to be ok. The patient reported no other problems and was not reported to be pregnant. At the time of the report, the patient had not recovered. The patient sought unspecified medical attention. Additional information has been requested. This is in follow-up to report (s) previously submitted on 2/14/2007. All was reported to be ok. The patient reported no other problems and was not reported to be pregnant. Addtional information is not expected.
Approximately 12 hours after the vaccine, experienced wheezing and difficulty breathing. Had to use an inhaler to regain normal breathing. Happened with first dose but patient did not report.
Started out itching and hives after 15 minutes of the vaccine, escalated to ?cotton balls in my throat? within 20 minutes of the vaccine. Gave Benadryl 50 mg by mouth followed by Epinephrine 1mg inter muscular, squad on scene and transported to attached hospital.
This spontaneous report as received from an office manager refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' pertinent medical history, concomitant medications and drug reactions or allergies was provided. On unknown dates in March 2017, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB injection, lot number M042322, expiration date: 21-FEB-2019, (dose, dose number, route of administration and injection site were not provided) for prophylaxis. According to the reporting office manager, the vaccine was exposed to the excursion conditions of 49.5 degrees Fahrenheit for 144 hours (from 16-FEB-2017 to 21-FEB-2017), 46.4 degrees Fahrenheit for 8 hours (from 27-FEB-2017 to 28-FEB-2017), 46.6 degrees Fahrenheit for 120 hours (from 10-MAR-2017 to 12-MAR-2017), 53.4 degrees Fahrenheit for 48 hours (from 14-MAR-2017 to 15-MAR-2017) and 53.4 degrees Fahrenheit for 48 hours (from 20-MAR-2017 to 21-MAR-2017). There was no previous temperature excursion reported. No adverse events were reported. No digital data logger was involved. Follow up information has been received from the reporting office manager via telephone call on 18-MAY-2017. The reporter stated that she would run a report and fax the patient identifiers and dates of vaccination. This is one of several reports received from the same reporter (linked with MARRS# 1704USA005744, 1706USA007378 and 1706USA007379). Additional information has been requested.; Sender's Comments:  US-009507513-1706USA007379: US-009507513-1706USA007378: US-009507513-1704USA005744:
This spontaneous report as received from a nurse refers to 57 patients of unknown age and gender. On an unknown date the patients were vaccinated with GARDASIL (dose and lot number was unknown) which was improperly stored. No adverse events were reported. The outcome of the events were unknown. No further information was provided. This case is linked to (MARRS # 1411USA009917, 1411USA009916, 1411USA009915, 1411USA009918) with the same reporter link. Additional information has been requested.
Booster dose of Modern a given at 3 months and 2 weeks. No adverse medical event experienced by patient.
UrticariaPruiritus, CHILLS AND BODY ACHES Narrative:
Pt passed out after waiting 15 minutes at pharmacy - hit his head at consultation window when coming toget vaccine card
RN realized moderna bivalent 0.5 ml given and child is 16 years old.  Moderna bivalent should be given to 18 years and older.
Client received 1st COVID vaccine of Pfizer (Lot# EW0185 expiration 05/22/2021). Client has been sitting in vaccination chair for 5 minutes. RN provided supplemental nutrition and fluids. Client accepted fluids, but refused nutrition, states "I'm not hungry". At 1455, RN and PHN observed Client leaning forward with hand on his head. Client appeared to be pale. At 1456, RN and PHN assisted Client to gravity chair. Vital signs at this time are blood pressure 106/60, heart rate 78, oxygen saturation 97%. Client reports dizziness and blurred vision. Client continues to sit in gravity chair drinking fluids. Client is accompanied by his mother. Per Client's mother, there is no past medical history, no known allergies, but history of dizziness with vaccines. At 1459, Client reports no blurred vision. At 1503 vital signs are blood pressure 112/62, heart rate 77, oxygen saturation 98. Client reports no blurred vision, no dizziness, no headache, no nausea, no chest pain. RN educated Client and mother about ED precautions and common adverse effects of COVID vaccine. AT 1503, vital signs are blood pressure 110/62, heart rate 75, oxygen saturation 99%. Client reports no blurred vision, no dizziness, no shortness of breath, no nausea, no chest pain, skin tone returns to appropriate coloration to ethnicity. At 1507, Client is able to stand up without complaints. Client left vaccination facility at 1508 with a steady gait accompanied by mother